Cargando…
METTL3 regulates breast cancer-associated alternative splicing switches
Alternative splicing (AS) enables differential inclusion of exons from a given transcript, thereby contributing to the transcriptome and proteome diversity. Aberrant AS patterns play major roles in the development of different pathologies, including breast cancer. N(6)-methyladenosine (m(6)A), the m...
Autores principales: | Achour, Cyrinne, Bhattarai, Devi Prasad, Groza, Paula, Román, Ángel-Carlos, Aguilo, Francesca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10020087/ https://www.ncbi.nlm.nih.gov/pubmed/36725888 http://dx.doi.org/10.1038/s41388-023-02602-z |
Ejemplares similares
-
ZFP207 sustains pluripotency by coordinating OCT4 stability, alternative splicing and RNA export
por: Malla, Sandhya, et al.
Publicado: (2022) -
Dissecting the effects of METTL3 on alternative splicing in prostate cancer
por: Wang, Lin, et al.
Publicado: (2023) -
Alternative splicing of METTL3 explains apparently METTL3-independent m(6)A modifications in mRNA
por: Poh, Hui Xian, et al.
Publicado: (2022) -
An Alternatively Spliced Variant of METTL3 Mediates Tumor Suppression in Hepatocellular Carcinoma
por: Xu, Rui-Yao, et al.
Publicado: (2022) -
Mettl3 Regulates Osteogenic Differentiation and Alternative Splicing of Vegfa in Bone Marrow Mesenchymal Stem Cells
por: Tian, Cheng, et al.
Publicado: (2019)